Talk:Fostamatinib
Appearance
This is the talk page for discussing improvements to the Fostamatinib article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
|
The following Wikipedia contributor may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view. |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Fostamatinib.
|
Assessment
[edit]Changed to Start class, given the COI and lack of MOS:MED compliance. --ἀνυπόδητος (talk) 13:44, 9 January 2019 (UTC)
Categories:
- C-Class pharmacology articles
- High-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class articles with conflicting quality ratings
- Start-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages
- C-Class chemicals articles
- Low-importance chemicals articles
- Articles edited by connected contributors